APA (7th ed.) Citation

Cattrini, C., Manfredi, M., Barboro, P., Ghirimoldi, M., Mennitto, A., Martini, V., . . . Gennari, A. (2022). 67P High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology, 33, S1403. https://doi.org/10.1016/j.annonc.2022.09.068

Chicago Style (17th ed.) Citation

Cattrini, C., et al. "67P High Levels of Circulating Ceramides Are Associated with Poor Prognosis in Patients with Metastatic Castration-resistant Prostate Cancer (mCRPC)." Annals of Oncology 33 (2022): S1403. https://doi.org/10.1016/j.annonc.2022.09.068.

MLA (9th ed.) Citation

Cattrini, C., et al. "67P High Levels of Circulating Ceramides Are Associated with Poor Prognosis in Patients with Metastatic Castration-resistant Prostate Cancer (mCRPC)." Annals of Oncology, vol. 33, 2022, p. S1403, https://doi.org/10.1016/j.annonc.2022.09.068.